Does Mounjaro Affect Contraception — and What Should You Do About It?

Tirzepatide slows gastric emptying, which may reduce absorption of oral contraceptives taken at the same time.
UK guidance recommends adding a non-oral contraceptive method (e.g. condoms) for the first four weeks of treatment and for four weeks after every dose increase.
There is currently no equivalent evidence that oral contraceptive absorption is reduced in women taking semaglutide (Wegovy).
Women who are pregnant, breastfeeding, or actively trying to conceive should not use Mounjaro; MHRA advises using reliable contraception during treatment and for a wash-out period before trying to conceive.

Yes, Mounjaro can affect how well oral contraceptives are absorbed. The MHRA advises that women taking the pill should add a non-oral contraceptive method (such as condoms) for the first four weeks of treatment and for four weeks after any dose increase. This is because tirzepatide slows gastric emptying, which may reduce how much of the pill reaches your bloodstream. It is a genuinely important practical point, and one our prescribers raise with every eligible patient before treatment begins. Mounjaro (tirzepatide) is a prescription-only medicine, so whether it is right for you and how to manage contraception alongside it is always a conversation with a prescriber, not a decision to make alone. If you are thinking about starting Mounjaro, or already taking it and now wondering about your pill, this page sets out what the evidence says, what remains uncertain, and who to speak to next.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to manage your contraception safely while taking Mounjaro

Why Mounjaro specifically changes the picture for pill users

The core reason tirzepatide can interfere with oral contraceptives comes down to how the medicine works in your gut. As a dual GIP and GLP-1 receptor agonist, Mounjaro slows the rate at which food and liquids move through your stomach. That delayed gastric emptying is part of why people feel fuller for longer on treatment. The unintended side of that same mechanism is that oral medicines taken alongside it (including the contraceptive pill) may sit in the stomach longer before being absorbed, and the peak concentration reaching your bloodstream may be lower than expected.

Whether that translates to a clinically meaningful reduction in contraceptive protection is not something the current evidence can answer with certainty for every formulation. What the MHRA and NHS guidance do say clearly is that the risk is real enough to act on. The interaction between Mounjaro and the contraceptive pill is not theoretical: it is the reason the UK product information specifically flags it. For women taking any oral hormonal contraceptive (combined or progestogen-only) the practical response is a backup barrier method for the windows described above. This is worth understanding before you start, not after.

There is also an indirect factor: in the early weeks of treatment, gastrointestinal side effects such as nausea and vomiting are common. Any episode of vomiting within a few hours of taking the pill may reduce its efficacy independently of the tirzepatide mechanism. Standard pill-missed-dose rules apply in that situation, and your prescriber or Patient Information Leaflet will explain what to do. The NHS tirzepatide medicines page covers this too.

The four-week rule: what the guidance actually says and when it applies

UK clinical guidance, drawing on MHRA advice and the NHS England weight-management-injections resource, is specific about the timing. For the first four weeks of Mounjaro treatment, and then for four weeks after each upward dose step, women who rely on the oral pill for contraception should use an additional non-oral method. Condoms are the straightforward choice. After those four-week windows, if no dose change is planned, the backup method can stop — though this is always worth confirming with the prescriber who manages your contraception, not just the one prescribing your weight-loss treatment.

If you are on a long-acting reversible contraceptive (an implant, hormonal or copper coil, injection, or patch) there is no equivalent concern about absorption because those routes do not depend on the gut at all. The absorption concern is specific to the pill, not to all hormonal methods.

This is also the moment, if you have not already, to think about what happens if your contraception fails while on treatment. Mounjaro is not recommended in pregnancy. The MHRA advises using effective contraception throughout treatment and for a period after stopping before trying to conceive. What that wash-out period looks like for you is a question for your prescriber, because it depends on your treatment history and your plans. NHS England's guidance on weight-management injections addresses contraception and HRT considerations directly.

Planning ahead: conception, pregnancy and stopping treatment

If you are not trying to conceive right now but want to in future, Mounjaro may still be appropriate, many women are in exactly that position. The requirement is to stop treatment in good time before trying for a pregnancy. How much time is enough is something your prescriber will advise on individually; it is not a figure to calculate from general guidance. What is clear is that Mounjaro is not suitable during pregnancy or breastfeeding, and is not recommended while trying to conceive. If a pregnancy occurs while you are on treatment, stop taking Mounjaro and contact your prescriber or GP promptly.

We hear from a lot of women who feel a bit caught between decisions here, wanting to manage their weight now, while keeping future options open. That tension is real and completely understandable. A prescriber who knows your full picture, including your contraception method, your reproductive plans, and any other medicines you take, is the right person to help you think through the timing. If you are unsure whether Mounjaro stops contraception from working altogether, that is one of the questions worth raising before you start treatment. If you take thyroid medication alongside tirzepatide, for example, how Mounjaro interacts with thyroid medicines is another conversation worth having before you start.

Women who are currently pregnant, breastfeeding, or actively trying to conceive should not start Mounjaro. This is not a prescriber's preference, it reflects the product licence. Any GP or prescriber should be told about these circumstances at the point of consultation, and any reputable service will screen for them. MHRA Drug Safety Updates provide the formal regulatory basis for these recommendations.

Talking to a prescriber before anything else changes

The practical takeaway from all of this is that changing your contraception (or ignoring the absorption concern and hoping for the best) are both decisions that benefit from a prescriber's view. At nume, every consultation is read and assessed by a GPhC-registered Independent Prescriber on the day it is submitted. Questions about concurrent medicines, including the pill, are part of what that review covers. If you are already mid-treatment and realise this is something you have not yet addressed, our prescribers are available for aftercare support seven days a week. You do not have to wait until your next scheduled review.

A wider look at everything that is known about Mounjaro and contraception is available if you want more detail, including less common contraceptive scenarios. For women who are specifically on the pill, a focused guide to how Mounjaro interacts with the contraceptive pill covers the practical steps you need to take alongside treatment. And if you are weighing up whether Mounjaro is the right route for you at all, starting a free consultation is the first step, one that places your specific circumstances in front of a real clinician, not a form that auto-approves. That matters especially when your question involves a prescription medicine and another prescription medicine at the same time.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions